A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Benign Prostatic Hyperplasia

In brief

This is a 24 week study evaluating the effects of botulinum toxin Type A on semen quality in patients with signs and symptoms of Benign Prostatic Hyperplasia (BPH).

Key facts

Study ID

NCT00894517

Run by

Allergan

People needed

61

Starts

2009-08-01

Expected to finish

2012-08-01

Last updated by the study team

2013-09-30

Who can join

Age: 45 and older, up to 70. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Symptoms due to an enlarged prostate
• Able to provide semen samples at required visits.

You may not qualify if…

• Previous use of any botulinum toxin for the treatment of any urological condition
• History of vasectomy
• History of undescended testicles or testicular trauma
• Subject who has not ejaculated for greater than 1 year
• History of prostate infection or any sexually transmitted disease, such as gonorrhea, within the previous 12 months
• History of bladder stones
• History of cancer in the prostate, testicles, or bladder
• Previous use of chemotherapy for cancer treatment
• History of urinary incontinence
• Previous prostate surgery

Where it is running

• Study site — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.